Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2018 - IJCMAS--ICV 2018: 95.39 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2019)
[Effective from January 1, 2019]
For more details click here

ICV 2018: 95.39
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2018: 95.39
For more details click here

See Guidelines to Authors
Current Issues

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2019.8(12): 542-561
DOI: https://doi.org/10.20546/ijcmas.2019.812.072


An Experimental Study on the Effect of Pyrimethamine-Loaded Niosomes in the Treatment of Acute Toxoplasmosis
Basma M. El-Mansory, Samy I. El-Kowrany, Sirria M. El-Marhoumy,Kholoud A. El-Nouby, Mona A. Abd Elazeem and Gamal M. El Maghraby
1Department of Medical Parasitology, Faculty of Medicine, Tanta University, Tanta, Egypt
2Department of Pathology, Faculty of Medicine, Tanta University, Tanta, Egypt
3Department of Pharmaceutical Technology, Faculty of Pharmacy,Tanta University, Tanta, Egypt
*Corresponding author
Abstract:

Toxoplasma gondii infection has a worldwide distribution. Pyrimethamine (PYR) is the most effective drug for treatment of toxoplasmosis. Unfortunately, it has low oral bioavailability which requires an increase in the dose that results in increased its side effects. Nanostructures showed promising potential to overcome this problem. This study aimed to evaluate the effect of intraperitoneal injection (IP) of PYR-loaded niosomes compared to PYR in the treatment of acute toxoplasmosis in experimentally infected mice. The study employed 240 mice that were divided into groups. Group I included Ia (20 uninfected untreated), Ib (20 infected untreated), Ic (non-infected and injected with placebo niosomes) and Id (20 non-infected mice injected with dimethyl sulfoxide). Groups II and III (a & b/each, 40 mice/each) were treated with PYR and PYR-loaded niosomes respectively in doses of 5 or 10 mg/kg/day for four successive days. Then all mice were sacrificed and their peritoneal fluids were examined by the scanning electron microscopy. Livers, spleens and brains were used for parasite count and for histopathological examination. This study showed that the niosomes improved the efficacy of PYR in the treatment of acute toxoplasmosis in mice. It was evidenced by increased the survival rate, decreased tachyzoites count, morphological changes of the tachyzoites and decreased inflammation. Niosomal PYR was effective at low dose with its efficacy being even greater than that of the solution even at high dose. It was concluded that PYR-niosomes formulation is a powerful alternative for reduction of PYR dose and its side effects.


Keywords: Toxoplasma gondii. Pyrimethamine. Niosomes. Nanostructures
Download this article as Download

How to cite this article:

Basma M. El-Mansory, Samy I. El-Kowrany, Sirria M. El-Marhoumy, Kholoud A. El-Nouby, Mona A. Abd Elazeem and Gamal M. El Maghraby. 2019. An Experimental Study on the Effect of Pyrimethamine-Loaded Niosomes in the Treatment of Acute Toxoplasmosis.Int.J.Curr.Microbiol.App.Sci. 8(12): 542-561. doi: https://doi.org/10.20546/ijcmas.2019.812.072